The company enjoys strong and relatively stable free cash flow, and this, combined with a fairly modest dividend, creates significant flexibility. Given the change in strategic course, we don't expect ...
Here are six topics that are worth bringing up with family members, including parents, kids, and partners. I wrote this article from the perspective of someone with a spouse, retired parents, and ...
Taxable-bond funds continued their tremendous year, gathering $59 billion of inflows in October. That marked their best month since April 2021 in absolute terms and when scaled for assets. Investors ...
We believe potential tailwinds have largely been incorporated into share prices and view the banking sector as fairly valued ...
If Kennedy is confirmed, we may lower our US vaccine sales estimates, although we don’t think reductions would be ...
With profit and cash flow improving, STE has been able to repay some of its borrowings, leaving net debt/equity at 2.1 times in 2023. Nonetheless, we think free cash flow will be positive, with ...
Fear has left the building. Here’s what that could spell for investors. The market is melting. Since the election, nearly ...
Vanguard Balanced Index VBAIX, a low-cost 60% US stock/40% US bond portfolio, epitomizes the firm’s straightforward approach ...
Leonardo DiCaprio marked his milestone 50th birthday in true Hollywood fashion, by throwing a glamorous (and by all accounts) raucous party that was reportedly held at the ultraexclusive estate of a ...
Donald Trump's victory in the 2024 presidential election has triggered a number of intriguing movements in the housing industry-but perhaps none more interesting than the hordes of celebrities vowing ...
The Morningstar US Market Index declined 2.1% last week, with healthcare especially weak, down 5.8%. Given the strength of recent results from companies in this sector, it seems likely that this is a ...
Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...